Glenmark Pharmaceuticals Ltd Half Yearly Results

Gross Sales

6,522.04

6,623.8

5,476.3

6,159.16

6,021.12

Excise Duty

0

0

0

0

0

Net Sales

6,522.04

6,623.8

5,476.3

6,159.16

6,021.12

Other Operating Income

121.72

54.18

93.36

84.29

79.58

Other Income

42.81

70.91

1,215.9

21.42

495.1

Total Income

6,686.57

6,748.89

6,785.56

6,264.86

6,595.79

Total Expenditure

5,855.32

5,487.86

5,797.47

5,721.25

5,994.6

PBIDT

831.25

1,261.03

988.09

543.61

601.19

Interest

119

88.06

282.9

233.07

206.24

PBDT

712.25

1,172.97

705.19

310.54

394.95

Depreciation

247.94

238.07

298.41

283.49

286.53

Minority Interest Before NP

0

0

0

0

0

Tax

99.55

282.79

1,290.29

-174.74

451.84

Deferred Tax

12.34

-42.61

661.57

90.22

-231.04

Reported Profit After Tax

352.42

694.72

-1,545.09

111.57

-112.38

Minority Interest After NP

-0.2

0.24

24.57

43.58

43.35

Net Profit after Minority Interest

352.62

694.48

-1,569.66

67.99

-155.73

Extra-ordinary Items

-372.82

0

-126.18

-287.23

-298.89

Adjusted Profit After Extra-ordinary item

725.44

694.48

-1,443.48

355.22

143.16

EPS (Unit Curr.)

12.5

24.61

0

-6.6

0

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

28.22

28.22

28.22

28.22

28.22

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

12.74

19.03

18.04

8.82

9.98

PBDTM(%)

-

-

-

-

-

PATM(%)

5.4

10.48

-28.21

1.81

-1.86